These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22590744)

  • 1. [NF-kB activation as a molecular basis of pathological process by metabolic syndrome].
    Kaĭdashev IP
    Fiziol Zh (1994); 2012; 58(1):93-101. PubMed ID: 22590744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
    Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic syndrome in young people.
    Poyrazoglu S; Bas F; Darendeliler F
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children.
    Mauras N; Delgiorno C; Kollman C; Bird K; Morgan M; Sweeten S; Balagopal P; Damaso L
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1060-8. PubMed ID: 20061420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of insulin resistance in the obese with metabolic syndrome.
    Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU
    Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition.
    van den Berg E; Kloppenborg RP; Kessels RP; Kappelle LJ; Biessels GJ
    Biochim Biophys Acta; 2009 May; 1792(5):470-81. PubMed ID: 18848880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice].
    León-Pedroza JI; González-Tapia LA; del Olmo-Gil E; Castellanos-Rodríguez D; Escobedo G; González-Chávez A
    Cir Cir; 2015; 83(6):543-51. PubMed ID: 26159364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in obese Thai children and adolescents.
    Iamopas O; Chongviriyaphan N; Suthutvoravut U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
    Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty.
    Tobisch B; Blatniczky L; Barkai L
    Pediatr Obes; 2015 Feb; 10(1):37-44. PubMed ID: 24227418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of metabolic syndrome in a vascular patient.
    Vykoukal D; Davies MG
    Vascular; 2012 Jun; 20(3):156-65. PubMed ID: 22700582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of vitamin D and metabolic syndrome: A review.
    Prasad P; Kochhar A
    Diabetes Metab Syndr; 2016; 10(2):105-12. PubMed ID: 25813139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach.
    Gupta AK; Prieto-Merino D; Dahlöf B; Sever PS; Poulter NR;
    Diabet Med; 2011 Aug; 28(8):941-7. PubMed ID: 21749444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular mechanisms between metabolic syndrome and breast cancer.
    Chen Y; Wen YY; Li ZR; Luo DL; Zhang XH
    Biochem Biophys Res Commun; 2016 Mar; 471(4):391-5. PubMed ID: 26891869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and right ventricle: an updated review.
    Tadic M; Ivanovic B; Cuspidi C
    Eur J Intern Med; 2013 Oct; 24(7):608-16. PubMed ID: 24001437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].
    Halmos T; Suba I
    Orv Hetil; 2008 Dec; 149(51):2403-11. PubMed ID: 19073451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome: focus on dyslipidemia.
    Ginsberg HN; Zhang YL; Hernandez-Ono A
    Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():41S-49S. PubMed ID: 16642962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.